Literature DB >> 21431494

Successful management of multiple esophagorespiratory fistulas using two types of stent: report of a case.

Yoichi Hamai1, Jun Hihara, Manabu Emi, Riki Okita, Katsuhiko Shimizu, Morihito Okada.   

Abstract

We herein describe a 41-year-old man with esophageal cancer who developed three esophagorespiratory fistulas (ERFs) that were successfully treated using one esophageal and three airway stents. A self-expandable metallic stent (SEMS) was initially inserted into the esophagus to close an ERF in the right bronchus. However, two new ERFs developed in the trachea and the left main bronchus 3 months later because of pressure necrosis and penetration of the esophageal SEMS. These secondary ERFs were subsequently closed using two silicone stents, together with one SEMS in the airway. This experience suggests that appropriate stenting can control multiple and large ERFs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431494     DOI: 10.1007/s00595-009-4298-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

1.  Oesophagorespiratory fistulas as a complication of self-expanding metal oesophageal stents.

Authors:  S Hasan; D Beckly; J Rahamim
Journal:  Endoscopy       Date:  2004-08       Impact factor: 10.093

Review 2.  Airway stenting.

Authors:  Yukihito Saito; Hiroji Imamura
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Double stenting for esophageal and tracheobronchial stenoses.

Authors:  H Nomori; H Horio; Y Imazu; K Suemasu
Journal:  Ann Thorac Surg       Date:  2000-12       Impact factor: 4.330

4.  Palliative treatment of malignant dysphagia with self-expanding metal stents: a 12-year experience.

Authors:  Martin Sundelöf; Daniel Ringby; Dag Stockeld; Lars Granström; Eduard Jonas; Jacob Freedman
Journal:  Scand J Gastroenterol       Date:  2007-01       Impact factor: 2.423

5.  Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas.

Authors:  William A Ross; Firas Alkassab; Patrick M Lynch; Gregory D Ayers; Jaffer Ajani; Jeffrey H Lee; Mike Bismar
Journal:  Gastrointest Endosc       Date:  2007-01       Impact factor: 9.427

6.  Double stenting of oesophagus and airways in palliative treatment of patients with oesophageal cancer is efficient but associated with a high morbidity.

Authors:  S Lecleire; M Antonietti; F Di Fiore; E Ben-Soussan; S Bota; M-F Hellot; L Thiberville; P Michel; E Lerebours; P Ducrotté
Journal:  Aliment Pharmacol Ther       Date:  2007-04-15       Impact factor: 8.171

7.  Successful airway stenting using silicone prosthesis for esophagobronchial fistula.

Authors:  Keisuke Miwa; Masahiro Mitsuoka; Kohsuke Tayama; Naofumi Tomita; Shinzo Takamori; Akihiro Hayashi; Kazuo Shirouzu
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

8.  A nationwide study of the use of self-expanding stents in patients with esophageal cancer in Sweden.

Authors:  U Wenger; J Luo; L Lundell; J Lagergren
Journal:  Endoscopy       Date:  2005-04       Impact factor: 10.093

9.  Phase I study of docetaxel (TXT) and 5-fluorouracil (5-FU) with concurrent radiotherapy in patients with advanced esophageal cancer.

Authors:  Jun Hihara; Kazuhiro Yoshida; Yoichi Hamai; Manabu Emi; Yoshiyuki Yamaguchi; Koichi Wadasaki
Journal:  Anticancer Res       Date:  2007 Jul-Aug       Impact factor: 2.480

Review 10.  Treatment options for esophageal strictures.

Authors:  Peter D Siersema
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-02-05
View more
  2 in total

1.  Successful Management of Esophageal Cancer With Perforation Using Bypass Surgery Followed by Definitive Chemoradiotherapy.

Authors:  Manato Ohsawa; Yoichi Hamai; Yuta Ibuki; Manabu Emi; Morihito Okada
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Surgical treatment of esophageal perforations: the importance of a primary repair.

Authors:  L Sulpice; M Rayar; B Laviolle; D Cunin; A Merdrignac; K Boudjema; Bernard Meunier
Journal:  Surg Today       Date:  2012-09-18       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.